SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Market Glass, Inc. | PRODUCT CODE: 2148664

Cover Image

PUBLISHER: Market Glass, Inc. | PRODUCT CODE: 2148664

Biopreservation

PUBLISHED:
PAGES: 259 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Team License: Up to 10 users)
USD 11115
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Biopreservation Market to Reach US$10.7 Billion by 2032

The global market for Biopreservation estimated at US$3.3 Billion in the year 2025, is expected to reach US$10.7 Billion by 2032, growing at a CAGR of 18.2% over the analysis period 2025-2032. Equipment Offering, one of the segments analyzed in the report, is expected to record a 19.9% CAGR and reach US$5.3 Billion by the end of the analysis period. Growth in the Media Offering segment is estimated at 17.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$904.0 Million While China is Forecast to Grow at 23.7% CAGR

The Biopreservation market in the U.S. is estimated at US$904.0 Million in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2032 trailing a CAGR of 23.7% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.7% and 16.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.7% CAGR.

Global Biopreservation Market - Key Trends and Drivers Summarized

Biopreservation technologies play a crucial role in extending the functional lifespan of biological materials such as cells, tissues, and organs, essential for a broad range of medical and scientific applications. This field has experienced significant growth due to advancements in preservation methods, increased government and private funding for healthcare research, and a rising demand across various medical and research sectors. Particularly beneficial in the realms of immunotherapies, vaccine production, and enzyme technology, biopreservation helps address the growing incidence of chronic diseases by maintaining the viability and functionality of biological materials. Furthermore, the technology incorporates sophisticated tools like microarrays and predictive models which streamline the preservation processes, enhancing diagnosis and treatment capabilities, especially in critical areas such as cardiology and gynecology.

The application of biopreservation is particularly noteworthy in biobanking and regenerative medicine, sectors that heavily rely on these technologies for stem cell preservation and the manufacturing of cell therapies compliant with Good Manufacturing Practices (GMP). Biopreservation supports the intricate requirements of maintaining 'living drugs' through their lifecycle, optimizing preservation media to meet regulatory standards and ensure successful commercialization. This is crucial in regenerative medicine where the viability of cell therapies must be maintained from collection through to administration. Moreover, low-temperature storage methods, like cryogenic and hypothermic storage, play a pivotal role in this regard by reducing metabolic rates and minimizing biochemical requirements, which is vital for preserving cellular function and integrity during storage.

Several growth drivers are propelling the biopreservation market, including technological advancements that improve the efficiency of biological material storage, the expansion of R&D in biotechnology and medicine, and the increasing prevalence of chronic diseases that necessitate advanced therapeutic solutions. The expansion of biobanks globally, which requires robust biopreservation to maintain the integrity of biological samples, along with significant governmental and private funding, further fuels this growth. Additionally, stringent regulatory requirements necessitate reliable biopreservation solutions to ensure that biologically derived therapeutic products are safe and effective for clinical use. Innovations like improved cryopreservation technologies and novel media formulations that enhance cell viability and recovery rates are also crucial. As the field evolves, the integration of these technological advancements with increased healthcare investments underscores the crucial role of biopreservation in advancing healthcare and research, promising continued expansion and innovation in the preservation and utilization of vital biological resources.

SCOPE OF STUDY:

The report analyzes the Biopreservation market by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Equipment Offering, Media Offering, Laboratory Information Management System Offering); Application (Bio-Banking Application, Regenerative Medicine Application, Drug Discovery Application); End-Use (Life Sciences & Healthcare End-Use, Research Laboratories End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

  • Atlanta Biologicals, Inc.
  • BioCision, LLC
  • BioGenix, LLC
  • BioLife Solutions, Inc.
  • Biomatrica, Inc.
  • LabVantage Solutions, Inc.
  • Panasonic Corporation
  • Qiagen, Inc.
  • Thermo Fisher Scientific, Inc.
  • VWR International LLC

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Show more
Product Code: MG7986

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Biopreservation - Global Key Competitors Percentage Market Share in 2026 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 27 Players Worldwide in 2026 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Biobanking Services Spurs Growth of Biopreservation Market
    • Advancements in Cryopreservation Techniques Propel Market Expansion
    • Increasing Focus on Regenerative Medicine Expands Addressable Market Opportunity
    • Rising Investments in Stem Cell Research Strengthens Business Case
    • Adoption of Biopreservation in Personalized Medicine Drives Market Adoption
    • Emergence of Advanced Biopreservation Media Throws the Spotlight on Innovation
    • Surge in Clinical Trials and Research Activities Accelerates Demand for Biopreservation
    • Technological Innovations in Automated Storage Systems Sustain Market Growth
    • Decentralization of Biopreservation Facilities Expands Addressable Market
    • Healthcare Spending Propels Market Dynamics
    • Need for Biopreservation in Vaccine Storage and Distribution
    • Need for Long-Term Storage Stability Create Demand for Advanced Solutions
    • Increasing Need for Preservation of Rare and Orphan Disease Samples Drives Adoption
    • Sustainability Concerns Generate Demand for Eco-Friendly Biopreservation Methods
    • Enhanced Efficacy and Safety of Preservation Techniques Propel Market Growth
    • Rising Popularity of Gene Therapy Expands Addressable Market for Biopreservation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 2: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2026 & 2032
    • TABLE 3: World Biopreservation Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
    • TABLE 4: World Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 5: World 8-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2026 & 2032
    • TABLE 6: World Recent Past, Current & Future Analysis for Equipment Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 7: World 8-Year Perspective for Equipment Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2026 & 2032
    • TABLE 8: World Recent Past, Current & Future Analysis for Media Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 9: World 8-Year Perspective for Media Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2026 & 2032
    • TABLE 10: World Recent Past, Current & Future Analysis for Laboratory Information Management System Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 11: World 8-Year Perspective for Laboratory Information Management System Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2026 & 2032
    • TABLE 12: World Recent Past, Current & Future Analysis for Bio-Banking Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 13: World 8-Year Perspective for Bio-Banking Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2026 & 2032
    • TABLE 14: World Recent Past, Current & Future Analysis for Regenerative Medicine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 15: World 8-Year Perspective for Regenerative Medicine Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2026 & 2032
    • TABLE 16: World Recent Past, Current & Future Analysis for Drug Discovery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 17: World 8-Year Perspective for Drug Discovery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2026 & 2032
    • TABLE 18: World Recent Past, Current & Future Analysis for Life Sciences & Healthcare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 19: World 8-Year Perspective for Life Sciences & Healthcare End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2026 & 2032
    • TABLE 20: World Recent Past, Current & Future Analysis for Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 21: World 8-Year Perspective for Research Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2026 & 2032

III. MARKET ANALYSIS

  • UNITED STATES
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 23: USA 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 24: USA Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 25: USA 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 26: USA Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 27: USA 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 29: Canada 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 31: Canada 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 33: Canada 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • JAPAN
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 35: Japan 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 37: Japan 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 39: Japan 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • CHINA
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 41: China 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 42: China Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 43: China 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 44: China Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 45: China 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • EUROPE
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 47: Europe 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 49: Europe 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 51: Europe 8-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2026 & 2032
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 53: Europe 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • FRANCE
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 55: France 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 56: France Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 57: France 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 58: France Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 59: France 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • GERMANY
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 61: Germany 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 63: Germany 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 65: Germany 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 67: Italy 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 69: Italy 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 71: Italy 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • UNITED KINGDOM
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 73: UK 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 74: UK Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 75: UK 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 76: UK Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 77: UK 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • SPAIN
    • TABLE 78: Spain Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 79: Spain 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 81: Spain 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 82: Spain Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 83: Spain 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • RUSSIA
    • TABLE 84: Russia Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 85: Russia 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 87: Russia 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 88: Russia Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 89: Russia 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • REST OF EUROPE
    • TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 91: Rest of Europe 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 93: Rest of Europe 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 95: Rest of Europe 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • ASIA-PACIFIC
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 97: Asia-Pacific 8-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2026 & 2032
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 99: Asia-Pacific 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
    • TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 101: Asia-Pacific 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 102: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 103: Asia-Pacific 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
  • AUSTRALIA
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 105: Australia 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
    • TABLE 106: Australia Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 107: Australia 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 108: Australia Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 109: Australia 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
  • INDIA
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 111: India 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
    • TABLE 112: India Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 113: India 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 114: India Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 115: India 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 117: South Korea 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
    • TABLE 118: South Korea Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 119: South Korea 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 120: South Korea Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 121: South Korea 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 123: Rest of Asia-Pacific 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
    • TABLE 124: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 125: Rest of Asia-Pacific 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 126: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
  • LATIN AMERICA
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 129: Latin America 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 130: Latin America Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 131: Latin America 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 132: Latin America Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 133: Latin America 8-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2026 & 2032
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 135: Latin America 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • ARGENTINA
    • TABLE 136: Argentina Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 137: Argentina 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 138: Argentina Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 139: Argentina 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 141: Argentina 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • BRAZIL
    • TABLE 142: Brazil Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 143: Brazil 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 144: Brazil Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 145: Brazil 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 147: Brazil 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • MEXICO
    • TABLE 148: Mexico Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 149: Mexico 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 150: Mexico Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 151: Mexico 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 153: Mexico 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • REST OF LATIN AMERICA
    • TABLE 154: Rest of Latin America Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 155: Rest of Latin America 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 156: Rest of Latin America Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 157: Rest of Latin America 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 159: Rest of Latin America 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • MIDDLE EAST
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
    • TABLE 160: Middle East Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 161: Middle East 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 162: Middle East Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 163: Middle East 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 165: Middle East 8-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2026 & 2032
    • TABLE 166: Middle East Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 167: Middle East 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • IRAN
    • TABLE 168: Iran Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 169: Iran 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 171: Iran 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 172: Iran Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 173: Iran 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • ISRAEL
    • TABLE 174: Israel Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 175: Israel 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 177: Israel 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 178: Israel Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 179: Israel 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • SAUDI ARABIA
    • TABLE 180: Saudi Arabia Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 181: Saudi Arabia 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 183: Saudi Arabia 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 184: Saudi Arabia Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 185: Saudi Arabia 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • UNITED ARAB EMIRATES
    • TABLE 186: UAE Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 187: UAE 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 189: UAE 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 190: UAE Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 191: UAE 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • REST OF MIDDLE EAST
    • TABLE 192: Rest of Middle East Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 193: Rest of Middle East 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 195: Rest of Middle East 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 196: Rest of Middle East Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 197: Rest of Middle East 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032
  • AFRICA
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
    • TABLE 198: Africa Recent Past, Current & Future Analysis for Biopreservation by Application - Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 199: Africa 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Bio-Banking Application, Regenerative Medicine Application and Drug Discovery Application for the Years 2026 & 2032
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Biopreservation by End-Use - Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 201: Africa 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Life Sciences & Healthcare End-Use, Research Laboratories End-Use and Other End-Uses for the Years 2026 & 2032
    • TABLE 202: Africa Recent Past, Current & Future Analysis for Biopreservation by Offering - Equipment Offering, Media Offering and Laboratory Information Management System Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 203: Africa 8-Year Perspective for Biopreservation by Offering - Percentage Breakdown of Value Sales for Equipment Offering, Media Offering and Laboratory Information Management System Offering for the Years 2026 & 2032

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!